Biotech Booster’s Post

Andrew Stephens, co-founder of PEdELISA Diagnostics, shares his experience in the Activator program. PEdELISA Diagnostics is a biotechnology startup that has developed a microarray-based immunoassay for rapid biomarker monitoring in an ICU environment to enable precision medicine in critical care. Are you an academic trainee (Post-doc/ PhD/MBA/MD/JD/MS) eager to build a life science startup? Whether you’re passionate about therapeutics, diagnostics, medtech, synthetic biology, or fields like food, energy, agriculture, climate, or consumer products, this is your opportunity to transform your research into a groundbreaking venture! Over the past 5 years, Nucleate’s Activator Program has supported 409+ venture teams, with our alumni raising over $370M to develop cutting-edge technologies. What We Offer: ▫️Completely free - Nucleate never takes equity or charges fees for its programs. ▫️Mentorship from industry leaders - Receive guidance from experienced mentors. ▫️Comprehensive educational programming - Learn from the best in workshops and seminars. ▫️Investor introductions - Get connected with investors ready to support your breakthrough. ▫️No forced incorporation - Focus on your venture at your own pace. If you have an idea (i.e., you’re an inventor), you can apply for: 🔬 Bio Track - for innovators in therapeutics, diagnostics, or tools. ♻️Eco Track - focused on food & agriculture, chemicals & energy, or consumer products. Don’t have an idea yet? Join a team as a scientific, business, or clinical contributor through our matching process. 📅 Application Deadline EXTENDED: NOV 6th, 2024 🔗 Application: apply.nucleate.org 🌐Learn more: nucleate.org/activator

As a Medical Biotechnology Master's graduate, we have a strong background in the field and can explore various startup ideas related to biotechnology and healthcare. Here are a few potential ideas you could consider: 1. Personalized Medicine: Develop a startup that focuses on personalized treatments and therapies based on an individual's genetic makeup and health data. This could involve using advanced biotechnology techniques like gene therapy, biomarker analysis, and therapeutic drug development. 2. Diagnostic Tools: Create innovative diagnostic tools or devices that can quickly and accurately assess a patient's health condition. This could include developing new methods for detecting diseases, analyzing biomarkers, or improving existing diagnostic processes. 3. Bioinformatics Solutions: Develop software or technology solutions that help analyze and interpret complex biological data, such as genomic sequencing or protein analysis. This could involve creating algorithms, machine learning models, or data visualization tools for researchers and healthcare professionals. 4. Drug Delivery Systems: Design novel drug delivery systems that improve the effectiveness and efficiency of medications. This could include developing targeted drug delivery platforms, nanotechnology-based drug carriers, or implantable devices for sustained release of drugs. 5. Point-of-Care Testing: Build portable and affordable devices for point-of-care testing in remote or resource-limited areas. These devices could enable quick and accurate diagnostics for diseases such as malaria, dengue, or HIV, helping to improve healthcare access in underserved communities. 6. Synthetic Biology: Explore the emerging field of synthetic biology and consider startup ideas that involve engineering biological systems to create new applications in healthcare, agriculture, or environmental conservation. This could include designing synthetic organisms, creating biofuels, or developing bioremediation solutions. Remember, starting a startup requires careful planning, market research, and understanding the regulatory landscape in the biotechnology and healthcare sectors. Consider collaborating with experts in the field, obtaining necessary licenses or certifications, and seeking funding or grants to support your startup idea. #Biotechnology #MedicalBiotechnology #Startup #Lab #Laboratory #GayathriMuddala Pandorum Technologies Aten Porus Lifesciences Sea6 Energy Pvt Ltd. Biomonadic Zenotis Healthcare Bharatbiocare

Are you ready to meet some of the most promising stars lighting up the UK's Biotechnology startup scene in Oxford? Their innovative solutions are transforming sectors like agriculture, health care, pharmaceuticals, AI, machine learning, sustainability and many more. Come dive into this world with us! https://lnkd.in/ghyAd4K7 Featuring: - Kyomei revolutionizing meat protein production with sustainable plant cell biology. - coding.bio, led by the innovative Simon Bornschein, taking artificial intelligence, life science, and therapeutics to the next level. - Etcembly Ltd, at the cutting edge of biotechnology and machine learning. - Oxford Silk Phage Technologies Ltd Technologies, founded by experts James Gilbert and Stephanie Lesage, combating surgical implant and wound infections with revolutionary biomaterial technology. - MetaGuideX Ltd, redefining the face of health diagnostics. - HydRegen, offering sustainable solutions for chemical manufacturing. - Nanolyse Technologies Ltd Technologies, founded by the savvy Imad Ahmed, making strides in analytical science with groundbreaking nanotech. - T-Cypher Bio led by Graham Ogg, striving to transform treatment for a range of diseases through their integrated platform, D-Cypher. - Accession Therapeutics Limited, under the guidance of Bent Jakobsen, Francis Yuan, and Nick Cross, reshaping cancer therapy. - Alethiomics, established by proficient researchers Adam Mead and Bethan Psaila, is focusing on revolutionary treatments for blood cancer patients. - OXVax Ltd, under the stewardship of Marcelo Bravo, developing a dendritic cell vaccine platform for solid tumor cancers. This fascinating journey is just one click away! #biotech #startups #innovation #UKStartups #Oxford #biotechnology

Startups in the biotechnology industry focus on developing innovative products and solutions related to various fields such as healthcare, agriculture, industrial processes, and environmental applications. Here are some key points about biotechnology startups: 1. Areas of focus: Common areas of focus for biotech startups include drug discovery and development, gene therapy, biomanufacturing, biomedical devices, biomaterials, bioinformatics, synthetic biology, biofuels, and agricultural biotechnology (e.g., crop engineering, biopesticides, biofertilizers). 2. Research and development: Biotech startups heavily invest in research and development activities, leveraging advanced techniques like genetic engineering, molecular biology, bioinformatics, and computational biology to develop innovative products and solutions. 3. Funding and investment: Biotech startups often require significant funding due to the capital-intensive nature of research and development, clinical trials, and regulatory approvals. They typically rely on venture capital, angel investors, government grants, and strategic partnerships with larger companies. 4. Intellectual property: Protecting intellectual property, such as patents, is crucial for biotech startups as their success often hinges on the exclusivity of their technologies or products. 5. Regulatory compliance: Biotech startups must navigate complex regulatory frameworks and comply with stringent regulations set by agencies like the Food and Drug Administration (FDA) or the Environmental Protection Agency (EPA), depending on their specific products or applications. 6. Talent and expertise: Biotech startups require a highly skilled and specialized workforce, including scientists, researchers, engineers, and experts in various disciplines such as molecular biology, biochemistry, genetics, bioinformatics, and regulatory affairs. 7. Collaboration and partnerships: Due to the interdisciplinary nature of biotechnology, startups often collaborate with academic institutions, research organizations, and established companies to leverage complementary expertise, resources, and infrastructure. 8. Ethical and social considerations: Biotech startups may face ethical and social concerns related to their work, such as biosafety, bioethics, and public perception, which they need to address transparently and responsibly. Successful biotech startups have the potential to revolutionize various industries, drive innovation, and create significant social and economic impact by developing solutions for pressing challenges in healthcare, agriculture, and environmental sustainability.

 💰 𝐂𝐨𝐧𝐬𝐭𝐫𝐮𝐜𝐭𝐢𝐯𝐞 𝐁𝐢𝐨 𝐒𝐞𝐜𝐮𝐫𝐞𝐬 £𝟒𝟑𝐌 𝐢𝐧 𝐒𝐞𝐫𝐢𝐞𝐬 𝐀 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 𝐭𝐨 𝐀𝐝𝐯𝐚𝐧𝐜𝐞 𝐆𝐫𝐨𝐮𝐧𝐝𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐆𝐞𝐧𝐨𝐦𝐞 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 💰 Constructive Bio, a synthetic genomics startup, has raised $75 million in total through the first close of its Series A fundraising, which brought in an additional £43 million. The round was led by Ahren, OMX Ventures, and Paladin Capital Group, with additional participation from Fine Structure Ventures, +ND Capital, and Jonathan Milner, founder of Abcam. Constructive Bio's cutting edge technology , which enables the company to write entire genomes from scratch and construct an entirely new biomolecule, will be developed faster thanks to the additional cash. The company aims to revolutionize industries ranging from pharmaceuticals to materials and consumer goods with its novel biomanufacturing capabilities  As part of the investment, Sir Gregory Winter, a biotechnologist who won the Nobel Prize, will will join the board of Constructive Bio, representing Ahren. It is anticipated that Sir Gregory would contribute his wealth of knowledge to assist the business in growing its technological and business applications. Ola (Aleksandra) Wlodek, CEO of Constructive Bio, said the funding will enable the company to bring breakthrough products and platforms to market, driving revenue growth through new and existing pathways.“Synthetic genomics is redefining how we harness biology. Our suite of proprietary technologies and incomparable team allows us to build novel materials and products that will revolutionise drug manufacturing and discovery.” The company, founded by Professor Jason Chin, operates on proprietary technology developed at the Medical Research Council’s Laboratory of Molecular Biology in Cambridge. Constructive Bio is the first to create a fully synthetic strain of E.coli and is now advancing its platform to engineer protein translation and create entirely new molecules. Constructive Bio’s capacity to produce fully programmable molecules is expected to accelerate drug development and improve biomanufacturing scalability. Its proprietary platforms are being deployed across a range of sectors, including pharmaceuticals, chemicals, and sustainable materials.  Professor Jason Chin, CSO, added: “Constructive Bio is the only company that can turn living cells into sustainable biofactories in which we can programme the sequence, composition and chemistry of proteins, and new biopolymers, With additional funding we are accelerating genome synthesis and design from years to days, more rapidly engineering cells’ machinery to make molecules with extra building blocks, and expanding the chemistry we can programme into molecules.” Source: https://lnkd.in/eMkTMf-4 Reach out for early access to #SyntheticBiology #KnowledgeHub

New and powerful data from the Catalan Bioregion today, during the Bioregió Report 2023 presentation in Barcelona, held by Biocat, BioRegion of Catalonia: - 1.400 companies in the Bioregion: They represent the 7.9% of the catalan GDP and they generate 270K work places.  - 1,7M€ of investment. UK is the main investor (in fact, cause AstraZeneca's Hub in Barcelona this year) - 25 new innovation hubs in Biotech & Health the last 5 years in Catalunya. - Spain is in the 5th place in Europe and 8th in the world in Clinical Trials ranking. 88% of them are made in catalan hospitals. A specific data: They haver talked about ADmit Therapeutics, a spin-off from Hospital Universitari de Bellvitge adn Bellvitge Biomedical Research Institute - IDIBELL , as one of the startups with more investment in 2023. Here you can download the Report: https://report.biocat.cat/

Have you noticed how biology and technology are converging? Biotechs are reshaping the world of life sciences  🚀🔍  There's a demand for experts who can seamlessly bridge the gap between these two domains - at the intersection of science and tech.  The future of pharmaceuticals is being shaped by innovators harnessing the potential of biotechnology to develop groundbreaking therapies and solutions. This trend isn't just about scientific breakthroughs though, it's also about creating a new wave of career opportunities.  What excites you most about the future of biotech? Share your thoughts in the comments! 👇 #weareevolve #biotechbooms #lifesciences

The UK faces a pivotal juncture. Innovations in biotechnology and AI have the potential to reshape critical sectors like health care and agriculture, transforming lives and powering national prosperity –­ but with great opportunity comes great responsibility. These technologies also carry risks if not developed prudently. This paper by Tony Blair Institute for Global Change highlights critical areas of focus for UK and a number of recommendations. One of the recommendations is: "Innovate UK should establish its own CERSI-style programme, developing new tools and standards to assess regulatory products, and offering information-sharing opportunities such as workshops, fellowships and competitions. Although this programme should eventually be deployed across multiple regulators, initial centres of excellence should begin their pilots in health, working alongside the Medicines and Healthcare products Regulatory Agency and the Regulatory Horizons Council to improve regulatory-science standards." Innovate UK (in collaboration with MHRA) have launched a discovery phase for UK Regulatory Science and Innovation Networks which is a fantastic step towards a coordinated approach to regulatory science in the UK. Innovate UK Department for Science, Innovation and Technology The University of Manchester Faculty of Biology, Medicine and Health UK Research and Innovation Medical Research Council BBSRC Newmarket Strategy BioIndustry Association (BIA) Babraham Research Campus Medicines and Healthcare products Regulatory Agency Bruntwood SciTech #regulatory #biotech #innovation

BIOT Tank is BACK for 2024, sponsored by Bio-Works Technologies! We are looking for start-up, early stage companies and teams of entrepreneurs seeking to develop and commercialize novel medical, healthcare, and biotechnology products to compete in a Shark Tank-like competition. Entrepreneurs are invited to give technical details of their company’s core technologies as well as share their value proposition and business model rationale. Technology sectors will include but are not limited to, diagnostics, medical devices, biologics and therapeutics, personalized medicine, upstream and downstream bioprocessing, modeling software, process analytical technologies, and drug delivery systems. Winners will be selected during the session and awards include a $8000 first prize selected by the judges, as well as a $2000 audience choice award selected by live voting. Judges will consist of a select group of venture capitalist, angel funding group leaders, and technology leaders from large and small technology companies and/or research institutions. Previous BIOT tank competitions were attended by more than 200 scientists, entrepreneurs, and venture capitalists, leading to great exposure for all companies selected to present. Submit your 60 second pitch by 2/10 using the form here: https://lnkd.in/dvFsES2c

Fueled by innovation and a skilled workforce, India's biotechnology sector is blossoming into a global powerhouse. This "sunrise sector," valued at over $80 billion, is projected to reach a staggering $300 billion by 2030. Spanning biopharmaceuticals, bio agriculture, and bioinformatics, it's a breeding ground for groundbreaking solutions. From being a leading producer of affordable medicines and vaccines to fostering a vibrant startup ecosystem brimming with biotech advancements, India is redefining the landscape of this dynamic field. With dedicated government support like the Department of Biotechnology, India's bio revolution is poised to leave an undeniable mark on the world stage.